灵康药业(603669.SH)：子公司参与全国药品集中采购拟中选

Core Viewpoint - Lingkang Pharmaceutical (603669.SH) announced that its wholly-owned subsidiary, Hainan Lingkang Pharmaceutical Co., Ltd., participated in the 11th national centralized procurement organized by the National Organization for Drug Procurement Office, with its product, injectable cefoperazone sodium, expected to be selected in this procurement process [1] Group 1 - Lingkang Pharmaceutical's subsidiary is involved in a significant national drug procurement initiative [1] - The product under consideration for selection is injectable cefoperazone sodium [1]